Woodstock Corp Sells 425 Shares of CVS Health Co. (NYSE:CVS)

Woodstock Corp lessened its position in shares of CVS Health Co. (NYSE:CVS) by 1.0% in the fourth quarter, HoldingsChannel reports. The fund owned 43,648 shares of the pharmacy operator’s stock after selling 425 shares during the period. Woodstock Corp’s holdings in CVS Health were worth $1,959,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. bought a new stake in CVS Health in the 3rd quarter valued at $25,000. Ridgewood Investments LLC lifted its holdings in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares in the last quarter. Livelsberger Financial Advisory bought a new stake in shares of CVS Health in the third quarter valued at about $31,000. Legacy Investment Solutions LLC bought a new position in CVS Health during the third quarter worth about $31,000. Finally, Reston Wealth Management LLC acquired a new stake in CVS Health in the 3rd quarter worth about $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Down 0.3 %

Shares of NYSE:CVS opened at $52.01 on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a market capitalization of $65.44 billion, a PE ratio of 13.20, a price-to-earnings-growth ratio of 0.72 and a beta of 0.59. The company has a fifty day moving average of $51.49 and a 200-day moving average of $56.39.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.21 EPS. On average, equities analysts predict that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.11%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Analysts Set New Price Targets

Several research analysts have recently commented on CVS shares. Mizuho lowered their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Truist Financial lowered their price objective on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $60.00 to $66.00 in a research report on Monday, November 18th. Finally, Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.